Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.5 - $8.91 $24,056 - $32,975
3,701 Added 29.43%
16,277 $126,000
Q1 2024

May 15, 2024

SELL
$5.37 - $8.35 $257,872 - $400,975
-48,021 Reduced 79.25%
12,576 $89,000
Q4 2023

Feb 14, 2024

BUY
$4.44 - $6.7 $46,233 - $69,767
10,413 Added 20.75%
60,597 $405,000
Q3 2023

Nov 14, 2023

BUY
$5.23 - $9.24 $126,163 - $222,896
24,123 Added 92.56%
50,184 $282,000
Q2 2023

Aug 14, 2023

BUY
$4.36 - $6.2 $51,033 - $72,571
11,705 Added 81.53%
26,061 $143,000
Q1 2023

May 15, 2023

SELL
$4.71 - $6.66 $14,539 - $20,559
-3,087 Reduced 17.7%
14,356 $89,000
Q4 2022

Feb 14, 2023

BUY
$4.06 - $5.71 $70,818 - $99,599
17,443 New
17,443 $81,000
Q2 2022

Aug 15, 2022

BUY
$5.84 - $20.02 $136,311 - $467,286
23,341 New
23,341 $138,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $375M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.